The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.

Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.

Parent entities and officers
Active 4
  • 1
    Yates, Jason Derick
    Managing Director born in June 1973
    Individual (20 offsprings)
    Officer
    2018-09-06 ~ dissolved
    OF - Director → CIF 0
  • 2
    Pritchard, Ian
    Finance Director born in December 1969
    Individual (23 offsprings)
    Officer
    2019-08-05 ~ dissolved
    OF - Director → CIF 0
  • 3
    Poynter, Caroline
    Commercial Director born in May 1964
    Individual (10 offsprings)
    Officer
    2018-09-06 ~ dissolved
    OF - Director → CIF 0
  • 4
    C.S.T. PHARMA GROUP HOLDINGS LIMITED - now
    ST TOPCO (UK) LIMITED - 2019-11-06
    5-7 Tintagel Way, Tintagel Way, Aldridge, Walsall, England
    Active Corporate (4 parents, 7 offsprings)
    Profit/Loss (Company account)
    911,544 GBP2023-05-01 ~ 2024-04-30
    Person with significant control
    2021-08-19 ~ dissolved
    PE - Ownership of shares – More than 25% but not more than 50%CIF 0
    PE - Ownership of voting rights - More than 25% but not more than 50%CIF 0
Ceased 5
  • 1
    O'connor, Daniel Mark
    Finance Director born in September 1981
    Individual (3 offsprings)
    Officer
    2018-09-06 ~ 2019-05-21
    OF - Director → CIF 0
  • 2
    Dally, Jonathan, Dr
    Director born in November 1969
    Individual
    Officer
    2018-09-06 ~ 2020-12-01
    OF - Director → CIF 0
  • 3
    Melville, Robert Arthur
    Manager born in January 1969
    Individual (9 offsprings)
    Officer
    2017-08-15 ~ 2018-09-06
    OF - Director → CIF 0
    Mr Robert Arthur Melville
    Born in January 1969
    Individual (9 offsprings)
    Person with significant control
    2017-08-15 ~ 2018-09-06
    PE - Has significant influence or controlCIF 0
  • 4
    Falzon, Carl Robert
    Commercial Director born in June 1977
    Individual (7 offsprings)
    Officer
    2018-09-06 ~ 2020-12-01
    OF - Director → CIF 0
  • 5
    Units 5-7, Tintagel Way, Aldridge, Walsall, West Midlands, United Kingdom
    Active Corporate (5 parents, 5 offsprings)
    Equity (Company account)
    20,813 GBP2024-04-30
    Person with significant control
    2017-08-15 ~ 2021-08-19
    PE - Ownership of shares – 75% or moreCIF 0
parent relation
Company in focus

ACRE PHARMACEUTICALS LIMITED

Standard Industrial Classification
46180 - Agents Specialised In The Sale Of Other Particular Products
Brief company account
Average Number of Employees
02021-05-01 ~ 2022-04-30
02020-05-01 ~ 2021-04-30
Debtors
100 GBP2022-04-30
100 GBP2021-04-30
Total Assets Less Current Liabilities
100 GBP2022-04-30
100 GBP2021-04-30
Equity
Called up share capital
100 GBP2022-04-30
100 GBP2021-04-30
Equity
100 GBP2022-04-30
100 GBP2021-04-30
Amounts Owed by Group Undertakings
Current
100 GBP2022-04-30
100 GBP2021-04-30

  • ACRE PHARMACEUTICALS LIMITED
    Info
    Registered number 10916419
    5-7 Tintagel Way, Aldridge, Walsall WS9 8ER
    Private Limited Company incorporated on 2017-08-15 and dissolved on 2023-04-25 (5 years 8 months). The company status is Dissolved.
    CIF 0
child relation
Offspring entities and appointments
Active 0
  • Not found in our database.
© 2022-2025 Polylogarithmic Technology Ltd. All rights reserved.
Contains public sector information retrieved at 24 April 2025 and licensed under the Open Government Licence v3.0.